by 
Histology and cytology procedures play a vital role in cancer diagnosis by examining tissue and cell samples under microscopes. Histology is used to study tissues at microscopic levels to examine disease processes or effects of drug therapies. Cytology examines cells found in bodily secretions, fluids and aspirated samples to assist in determining whether abnormal or diseased cells are present. With the growing global cancer burden and rising awareness about early detection, the demand for histology and cytology procedures has increased tremendously. The global histology and cytology market size is estimated to be valued at US$ 22.3 billion in 2023 and is expected to exhibit a CAGR of 14% over the forecast period 2024 to 2031.
Market key trends:
Digital pathology is gaining traction in the histology and cytology market. The increasing adoption of whole slide imaging systems offers several advantages over traditional microscopy such as remote consultation, sharing of case data globally, and integration with laboratory information systems for improved workflow efficiency. Several leading manufacturers are focusing on development of advanced whole slide scanners with enhanced scanning speed, resolution and automated digital analysis capabilities. This trend is expected to drive the digitalization of histopathology laboratories worldwide. Implementation of digital pathology solutions can help improve turnaround time, enhance throughput in high volume settings and enable teleconsultations for second opinion from expert pathologists.
Porter’s Analysis
Threat of new entrants: The histology and cytology market poses moderate threat of new entrants due to high capital requirement and expertise needed for equipment and technology. This protects the existing key players in the market.
Bargaining power of buyers: The bargaining power of buyers is moderate as the demand for histology and cytology tests is growing owing to increasing prevalence of cancer and other diseases.
Bargaining power of suppliers: The bargaining power of suppliers is low due to the availability of variety of suppliers for raw materials, reagents and other consumables in the histology and cytology market.
Threat of new substitutes: There is low threat of new substitutes for histology and cytology tests as procedures like immunohistochemistry, in-situ hybridization require special equipment and expertise.
Competitive rivalry: Globally, the histology and cytology market is dominated by major players with their brand recognition and large product portfolio.
Key Takeaways
The global histology and cytology market is expected to witness high growth during the forecast period of 2024-2031.
Regional analysis: North America is expected to dominate the histology and cytology market owing to rising awareness regarding disease diagnosis and presence of key players. The Asia Pacific region is anticipated to grow at fastest pace during the forecast period owing to growing healthcare infrastructure and increasing disposable income.
Key players operating in the histology and cytology market are F. Hoffmann-La Roche Ltd, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck KGaA, bioMérieux SA, BD, Hologic Inc., and Sysmex Corporation. Thermo Fisher Scientific offers a wide range of histology and cytology instruments, reagents, software, consumables and services dedicated in tissue diagnosis. BD offers BD FACSDiva software, image analyzer systems and consumables including slides, cassettes and media for histology and cytology.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
